Mortality and translocation assay to study the protective capacity of Bifidobacterium lactis INL1 against Salmonella Typhimurium infection in mice

Beneficial Microbes

Volumn 5, Issue 4, 2014, Pages 427-436

  Zacarias M F ^a   Reinheimer, J ^a   Forzani, L ^b   Grangette, C ^c   Vinderola, G ^a  

^a UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

^b Instituto de Matematica Aplicada del Litoral   (Argentina)

^c INSERM U1019   (France)

Author keywords

Bifidobacteria; Infection; Mouse model; Probiotic; Salmonella

Indexed keywords

CYTOKINE; PROBIOTIC AGENT; SECRETORY IMMUNOGLOBULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSLOCATION; BIFIDOBACTERIUM ANIMALIS; BIOASSAY; BREAST MILK; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG EFFECT; INFECTION PREVENTION; INTESTINE INFECTION; LIVER PARENCHYMA; MALE; MORTALITY; MOUSE; NONHUMAN; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SPLEEN; SURVIVAL RATE; ANIMAL; ANTIBIOSIS; BACTERIAL LOAD; BAGG ALBINO MOUSE; BIFIDOBACTERIUM; DISEASE MODEL; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; LIVER; MICROBIOLOGY; PATHOLOGY; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SALMONELLA INFECTIONS, ANIMAL; SURVIVAL;

ANIMALS; ANTIBIOSIS; BACTERIAL LOAD; BACTERIAL TRANSLOCATION; BIFIDOBACTERIUM; DISEASE MODELS, ANIMAL; HUMANS; LIVER; MALE; MICE, INBRED BALB C; MILK, HUMAN; PROBIOTICS; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM; SPLEEN; SURVIVAL ANALYSIS;

EID: 84907022844     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2013.0086     Document Type: Article

References (45)

1. Bao, S., Beagley, K.W., France, M.P., Shen, J. and Husband, A.J., 2000. Interferon-gamma plays a critical role in intestinal immunity against Salmonella Typhimurium infection. Immunology 99: 464-472.
2. Binnendijk, K.H. and Rijkers, G.T., 2013. What is a health benefit? An evaluation of EFSA opinions on health benefits with reference to probiotics. Beneficial Microbes 4: 223-230.
3. Bovee-Oudenhoven, I.M., Ten Bruggencate, S.J., Lettink-Wissink, M.L. and Van der Meer, R., 2003. Dietary fructo-oligosaccharides and lactulose inhibit intestinal colonisation but stimulate translocation of Salmonella in rats. Gut 52: 1572-1578.
4. Brandtzaeg, P., Bjerke, K., Kett, K., Kvale, D., Rognum, T.O., Scott, H., Sollid, L.M. and Valnes, K., 1987. Production and secretion of immunoglobulins in the gastrointestinal tract. Annals of Allergy, Asthma and Immunology 59: 21-39.
5. Castillo, N.A., Perdigo´n, G. and De LeBlanc, A., 2011. Oral administration of a probiotic Lactobacillus modulates cytokine production and TLR expression improving the immune response against Salmonella enterica serovar Typhimurium infection in mice. BMC Microbiology 11: 177.
6. De Moreno de LeBlanc, A., Castillo, N.A. and Perdigo´n, G., 2010. Anti-infective mechanisms induced by a probiotic Lactobacillus strain against Salmonella enterica serovar Typhimurium infection. International Journal of Food Microbiology 138: 223-231.
7. Ferna´ndez, L., Langa, S., Marti´n, V., Maldonado, A., Jime´nez, E., Marti´n, R. and Rodri´guez, J.M., 2013. The human milk microbiota: origin and potential roles in health and disease. Pharmacological Research 69: 1-10.
8. Foligne´, B., Daniel, C. and Pot, B., 2013. Probiotics from research to market: the possibilities, risks and challenges. Current Opinion in Microbiology 16: 284-292.
9. Food and Agriculture Organization of the United Nations/World Health Organization (FAO/WHO), 2002. Guidelines for the evaluation of probiotics in food. Report of a Joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food. Available at: ftp://ftp.fao.org/es/esn/food/wgreport2.pdf.
10. Forbes, S.J., Eschmann, M. and Mantis, N.J., 2008. Inhibition of Salmonella enterica serovar Typhimurium motility and entry into epithelial cells by a protective antilipopolysaccharide monoclonal immunoglobulin A antibody. Infection and Immunity 76: 4137-4144.
11. Galdeano, C.M., De Moreno de Leblanc, A., Carmuega, E., Weill, R. and Perdigo´n, G., 2009. Mechanisms involved in the immunostimulation by probiotic fermented milk. Journal of Dairy Research 76: 446-454.
12. Gerritsen, J., Timmerman, H.M., Fuentes, S., Van Minnen, L.P., Panneman, H., Konstantinov, S.R., Rombouts, F.M., Gooszen, H.G., Akkermans, L.M., Smidt, H. and Rijkers, G.T., 2011. Correlation between protection against sepsis by probiotic therapy and stimulation of a novel bacterial phylotype. Applied and Environmental Microbiology 77: 7749-7756.
13. Gill, H.S., Shu, Q., Lin, H., Rutherfurd, K.J. and Cross, M.L. 2001. Protection against translocating Salmonella Typhimurium infection in mice by feeding the immuno-enhancing probiotic Lactobacillus rhamnosus strain HN001. Medical Microbiology and Immunology 190: 97-104.
14. Gueimonde, M., Laitinen, K., Salminen, S. and Isolauri, E., 2007. Breast milk: a source of bifidobacteria for infant gut development and maturation? Neonatology 92: 64-66.
15. Heikkila¨, M.P. and Saris, P.E.J., 2003. Inhibition of Staphylococcus aureus by the commensal bacteria of human milk. Journal of Applied Microbiology 95: 471-478.
16. Heithoff, D.M., Shimp, W.R., House, J.K., Xie, Y., Weimer, B.C., Sinsheimer, R.L. and Mahan, M.J., 2012. Intraspecies variation in the emergence of hyperinfectious bacterial strains in nature. PLoS Pathogens 8: e1002647.
17. Kilkenny, C., Browne, W.J., Cuthill, I.C., Emerson, M. and Altman, D.G., 2010. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biology 8: e1000412.
18. Lima-Filho, J.V., Vieira, L.Q., Arantes, R.M. and Nicoli, J.R., 2004. Effect of the Escherichia coli EMO strain on experimental infection by Salmonella enterica serovar Typhimurium in gnotobiotic mice. Brazilian Journal of Medical and Biological Research 37: 1005-1013.
19. MacPherson, A.J., Geuking, M.B. and McCoy, K.D., 2012. Innate and adaptive immunity in host-microbiota mutualism. Frontiers in Bioscience 4: 685-498.
20. Maia, O.B., Duarte, R., Silva, A.M., Cara, D.C. and Nicoli, J.R., 2001. Evaluation of the components of a commercial probiotic in gnotobiotic mice experimentally challenged with Salmonella enterica subsp. enterica ser. Typhimurium. Veterinary Microbiology 79: 183-189.
21. Mantis, N.J. and Forbes, S.J., 2010. Secretory IgA: arresting microbial pathogens at epithelial borders. Immunological Investigations 39: 383-406.
22. Marti´n, R., Langa, S., Reviriego, C., Jime´nez, E., Mari´n, M. L., Xaus, J., Ferna´ndez L. and Rodri´guez, J.M., 2003. Human milk is a source of lactic acid bacteria for the infant. Journal of Pediatrics 143: 754-758.
23. Martins, A.K., Martins, F.S., Gomes, D.A., Elian, S.D., Vieira, A.T., Teixeira, M.M., Cara, D.C., Nardi, R.M. and Nicoli, J.R., 2010. Evaluation of in vitro antagonism and of in vivo immune modulation and protection against pathogenic experimental challenge of two probiotic strains of Bifidobacterium animalis var. lactis. Archives of Microbiology 192: 995-1003.
24. Martins, F.S., Nardi, R.M., Arantes, R.M., Rosa, C.A., Neves, M.J. and Nicoli, J.R., 2005. Screening of yeasts as probiotic based on capacities to colonize the gastrointestinal tract and to protect against enteropathogen challenge in mice. Journal of General and Applied Microbiology 51: 83-92.
25. Martins, F.S., Rodrigues, A.C., Tiago, F.C., Penna, F.J., Rosa, C.A., Arantes, R.M., Nardi, R.M., Neves, M.J. and Nicoli, J.R., 2007. Saccharomyces cerevisiae strain 905 reduces the translocation of Salmonella enterica serotype Typhimurium and stimulates the immune system in gnotobiotic and conventional mice. Journal of Medical Microbiology 56: 352-359.
26. Martins, F.S., Veloso, L.C., Arantes, R.M. and Nicoli, J.R., 2009. Effects of yeast probiotic formulation on viability, revival and protection against infection with Salmonella enterica ssp. enterica serovar Typhimurium in mice. Letters in Applied Microbiology 49: 738-744.
27. Mastroeni, P. and Sheppard, M., 2004. Salmonella infections in the mouse model: host resistance factors and in vivo dynamics of bacterial spread and distribution in the tissues. Microbes and Infection 6: 398-405.
28. Nauta, A.J., Ben Amor, K., Knol, J., Garssen, J. and Van der Beek, E., 2013. Relevance of pre- and postnatal nutrition to development and interplay between the microbiota and metabolic and immune systems. American Journal of Clinical Nutrition 98: 586S-593S.
29. Paul, G., Khare, V. and Gasche, C., 2012 Inflamed gut mucosa: downstream of interleukin-10. European Journal of Clinical Investigation 42: 95-109.
30. Petersen, A., Heegaard, P.M., Pedersen, A.L., Andersen, J.B., Sørensen, R.B., Frøkiaer, H., Lahtinen, S.J., Ouwehand, A.C., Poulsen, M. and Licht, T.R., 2009. Some putative prebiotics increase the severity of Salmonella enterica serovar Typhimurium infection in mice. BMC Microbiology 9: 245.
31. Putaala, H., Barrangou, R., Leyer, G.J., Ouwehand, A.C., Hansen, E.B., Romero, D.A. and Rautonen, N., 2010. Analysis of the human intestinal epithelial cell transcriptional response to Lactobacillus acidophilus, Lactobacillus salivarius, Bifidobacterium lactis and Escherichia coli. Beneficial Microbes 1: 283-295.
32. Ren, Z., Gay, R., Thomas, A., Pae, M., Wu, D., Logsdon, L., Mecsas, J. and Meydani, S.N., 2009. Effect of age on susceptibility to Salmonella Typhimurium infection in C57BL/6 mice. Journal of Medical Microbiology 58: 1559-1567.
33. Rodrigues, A.C., Cara, D.C., Fretez, S.H., Cunha, F.Q., Vieira, E.C., Nicoli, J.R. and Vieira, L.Q., 2000. Saccharomyces boulardii stimulates sIgA production and the phagocytic system of gnotobiotic mice. Journal of Applied Microbiology 89: 404-414.
34. Silva, A.M., Bambirra, E.A., Oliveira, A.L., Souza, P.P., Gomes, D.A., Vieira, E.C. and Nicoli, J.R., 1999. Protective effect of bifidus milk on the experimental infection with Salmonella enteritidis subsp. Typhimurium in conventional and gnotobiotic mice. Journal of Applied Microbiology 86: 331-336.
35. Silva, A.M., Barbosa, F.H., Duarte, R., Vieira, L.Q., Arantes, R.M. and Nicoli, J.R., 2004. Effect of Bifidobacterium longum ingestion on experimental salmonellosis in mice. Journal of Applied Microbiology 97: 29-37.
36. Suitso, I., Jõgi, E., Talpsep, E., Naaber, P., Lõivukene, K., Ots, M.L., Michelson, T. and Nurk, A., 2010. Protective effect by Bacillus smithii TBMI12 spores of Salmonella serotype Enteritidis in mice. Beneficial Microbes 1: 37-42.
37. Ten Bruggencate, S.J., Bovee-Oudenhoven, I.M., Lettink-Wissink, M.L. and Van der Meer, R., 2003. Dietary fructo-oligosaccharides dose-dependently increase translocation of Salmonella in rats. Journal of Nutrition 133: 2313-2318.
38. Truusalu, K., Mikelsaar, R.H., Naaber, P., Karki, T., Kullisaar, T., Zilmer, M. and Mikelsaar, M., 2008. Eradication of Salmonella Typhimurium infection in a murine model of typhoid fever with the combination of probiotic Lactobacillus fermentum ME-3 and ofloxacin. BMC Microbiology 8: 132.
39. Vinderola, C.G., Duarte, J., Thangavel, D., Perdigo´n, G., Farnworth, E. and Matar, C., 2005. Immunomodulating capacity of kefir. Journal of Dairy Research 72: 195-202.
40. Vinderola, G., Matar, C. and Perdigo´n, G., 2007. Milk fermented by Lactobacillus helveticus R389 and its non-bacterial fraction confer enhanced protection against Salmonella enteritidis serovar Typhimurium infection in mice. Immunobiology 212: 107-118.
41. Vinderola, G., Zacari´as, M.F., Bockelmann, W., Neve, H., Reinheimer, J. and Heller, K.J., 2012. Preservation of functionality of Bifidobacterium animalis subsp. lactis INL1 after incorporation of freeze-dried cells into different food matrices. Food Microbiology 30: 274-280.
42. Watson, K.G. and Holden, D.W., 2010. Dynamics of growth and dissemination of Salmonella in vivo. Cellular Microbiology 12: 1389-1397.
43. Wijburg, O.L., Uren, T.K., Simpfendorfer, K., Johansen, F.E., Brandtzaeg, P. and Strugnell, R.A., 2006. Innate secretory antibodies protect against natural Salmonella typhimurium infection. Journal of Experimental Medicine 203(1): 21-26.
44. Zacari´as, M.F., Binetti, A., Laco, M., Reinheimer, J. and Vinderola, G., 2011. Preliminary technological and probiotic characterization of bifidobacteria isolated from breast milk for use in dairy products. International Dairy Journal 21: 548-555.
45. Zoumpopoulou, G., Foligne, B., Christodoulou, K., Grangette, C., Pot, B. and Tsakalidou, E., 2008. Lactobacillus fermentum ACA-DC 179 displays probiotic potential in vitro and protects against trinitrobenzene sulfonic acid (TNBS)-induced colitis and Salmonella infection in murine models. International Journal of Food Microbiology 121: 18-26.